These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 11816483

  • 1. [Anti-emetic effects of ondansetron hydrochloride throughout courses of cytotoxic chemotherapy].
    Nishida T, Yakushiji M, Ohizumi K, Noda S, Rikimaru T, Matsuoka K.
    Gan To Kagaku Ryoho; 2002 Jan; 29(1):81-7. PubMed ID: 11816483
    [Abstract] [Full Text] [Related]

  • 2. [Clinical usefulness of ondansetron hydrochloride for nausea and vomiting during repeated courses of chemotherapy for malignant lymphoma--impact of prognosis announcement on anti-emetic effect and evaluation of patient perception of chemotherapy-associated adverse events].
    Kodama F, Mohri H, Motomura S, Fukawa H, Tanabe J, Koharasawa H, Kanamori H, Hashimoto Y, Harano H, Sakai R, Tomita N, Fujimaki K, Takemura S, Hattori M.
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):273-9. PubMed ID: 11865634
    [Abstract] [Full Text] [Related]

  • 3. [Examination on efficacy and safety of concurrent use of ondansetron hydrochloride and steroid in lung cancer patients on cisplatin].
    Horichi N, Taguchi T, Furue H, Ikeda M, Tsukakoshi S.
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):953-60. PubMed ID: 11478144
    [Abstract] [Full Text] [Related]

  • 4. [Value of the combination of oral ondansetron with methylprednisolone as soon as the first cure in mild emetogenic chemotherapy. Groupe français d'étude de l'ondansétron].
    Coiffier B, Khayat D, Misset JL, Votan B.
    Bull Cancer; 1997 Aug; 84(8):781-7. PubMed ID: 9339181
    [Abstract] [Full Text] [Related]

  • 5. [Examination on efficacy and safety of concurrent use of ondansetron hydrochloride and steroid in gynecological cancer patients on cisplatin].
    Eguchi F, Taguchi T, Furue H, Ikeda M, Tsukakoshi S, Gan KenKyu-kai (the Cancer Study Group).
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1423-9. PubMed ID: 11681251
    [Abstract] [Full Text] [Related]

  • 6. [Clinical efficacy of GG032X tablets, a new dosage form of ondansetron (fast dispersing tablet), on cisplatin-induced nausea and emesis].
    Ariyoshi Y, Nukariya N, Akasaka Y, Suminaga M, Ota J, Ikeda M, Taguchi T.
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):995-1011. PubMed ID: 9212810
    [Abstract] [Full Text] [Related]

  • 7. [Examination of inhibitory effect, safety and usefulness of SN-307 (ondansetron) administered orally once daily for 3-5 consecutive days on nausea and emesis associated with non-platinum anti-cancer drugs].
    Suminaga M, Furue H, Taguchi T, Ota K, Niitani H, Tsukagoshi S, Ariyoshi Y, Ikeda M, Akasaka Y, Ohta J.
    Gan To Kagaku Ryoho; 1992 Sep; 19(11):1891-903. PubMed ID: 1387775
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
    Pradermdee P, Manusirivithaya S, Tangjitgamol S, Thavaramara T, Sukwattana P.
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Incidence of emesis in outpatients on chemotherapy for breast cancer and the clinical efficacy of ondansetron hydrochloride tablets].
    Ishida T, Kusaba T, Hayakawa H.
    Gan To Kagaku Ryoho; 2002 May; 29(5):723-8. PubMed ID: 12040676
    [Abstract] [Full Text] [Related]

  • 13. [Phase III clinical studies with ondansetron (Qilu) in the prophylaxis of nausea and vomiting induced by non-cisplatin chemotherapy].
    Zhou J, Xu B, Zhou A.
    Zhonghua Zhong Liu Za Zhi; 1997 Nov; 19(6):460-2. PubMed ID: 10920884
    [Abstract] [Full Text] [Related]

  • 14. [Effect of concurrent use of ondansetron hydrochloride and dexamethasone against nausea and vomiting in lung cancer patients receiving cisplatin].
    Tanimura S, Banba J, Tomoyasu H, Masaki M.
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2275-81. PubMed ID: 9881085
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Antiemetic effect of ondansetron in recurrent chemotherapy with cisplatin].
    Marty M, Richard A, d'Allens H.
    Bull Cancer; 1993 Jul; 80(7):618-23. PubMed ID: 8204942
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Anti-emetic effect and safety of consecutive use of ondansetron injection in cisplatin-induced nausea and emesis].
    Akasaka Y, Taguchi T, Ota K, Furue H, Niitani H, Tsukagoshi S, Ariyoshi Y, Ikeda M, Ohta J, Suminaga M.
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1359-74. PubMed ID: 1386977
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.